TriNetX

Join our insightful webinar focusing on the latest US Food and Drug Administration (FDA) guidelines on diversity in clinical trials. Register today to explore the latest FDA guidelines on clinical trial diversity and how compliance with these standards can be achieved. https://ow.ly/gVyt50TQ8u2

In collaboration with our global network of #healthcare organizations, TriNetX is positioning itself as a critical partner in the future of research and clinical trials. Through a commitment to empowering research, fostering collaboration, and enhancing #ClinicalTrial opportunities, we’re setting new standards for what’s possible in the healthcare space. Read more on our blog. https://ow.ly/9zXM50UrI57

Discover an insightful webinar that focuses on the transformative potential of real-world data (RWD) in clinical research and healthcare strategy. https://ow.ly/BcAr50UrHK9

The integration of Real-World Evidence (RWE) into oncology drug development and regulatory submissions is becoming increasingly important, particularly considering new European regulations like the JCA. Learn How RWE is Revolutionizing Health Technology Assessments and Regulatory Standards in our recent blog: https://ow.ly/XLaT50UrRg8

Dive deeper into Opportunities for Responsible AI in Clinical Research & Drug Development. Download our ebook to explore the responsible use of AI in advancing scientific discoveries and improving healthcare: https://lnkd.in/eqFqE7dh

Navigating data acquisition complexities shouldn’t be an insurmountable research challenge. TriNetX is here to simplify the process, saving precious time. Get an inside look at curated data sets in top therapeutic areas: CardioMetabolic, Respiratory Syncytial Virus (#RSV), Inflammatory Bowel Disease (#IBD), and Hypertrophic Cardiomyopathy (#HCM). Download now. https://ow.ly/kPlF50UnpNt

At TriNetX, we’re thrilled to be optimizing cancer #ClinicalTrials with external control arms, offering clinical affairs and medical affairs teams several key advantages when it comes to #oncology studies. Our latest blog explores how TriNetX real-world data (#RWD) and real-world evidence (#RWE) solutions are contributing to #ECAs and helping to shape the future of oncology research. Learn more: https://ow.ly/oe7350UnpLB

The future of #pharmacovigilance is here! With advances in #RWD, #AI, and regulation, drug safety monitoring is reaching new heights. Discover how these factors are reshaping the #healthcare industry in our latest blog - https://ow.ly/m5L850UnpG5

Whether you’re designing a clinical trial or navigating global study complexities, real-world data (RWD) is the key to breaking barriers and optimizing outcomes. Download our playbook and see how TriNetX is pioneering the future of trials. From protocol design and site identification powered by #RWD insights to leveraging #AI and machine learning for more diverse, complex, and global studies, we'll help you rethink your approach and improve feasibility and site ID. Download your copy today: https://lnkd.in/eHvF6vRz

Attending #ASH2024? Be sure to check out our poster presentation on the "Evolution of Treatment Patterns and Survival Outcomes in European Patients with Multiple Myeloma (2012–2023) through the Honeur Federated Data Network" and discover how advancements like anti-CD38 therapies are improving survival outcomes for multiple myeloma patients. Learn more about our oncology experts and how they can help you https://ow.ly/Ew3650UlOjs